Clicky

Handok(002390)

Description: Handok Inc. operates as an integrated pharmaceutical company. The company provides ETC and OTC drugs, medical devices, and in-vitro diagnostics instruments and devices. It focuses on various therapeutic areas, such as oncology, diabetes and metabolic disorders, CNS orphan diseases, eye disorders, and other disease areas. The company also offers healthcare products comprising food supplements under the NatureSet and Culturelle brands; food and beverages; and medical nutrition products. Handok Inc. has a strategic collaboration agreement with AUM Biosciences Pte. Ltd. and CMG Pharmaceutical Co. Ltd. for the development, manufacturing, and commercialization of CHC2014, a pan-TRK inhibitor for cancer treatment. The company was formerly known as Handok Pharmaceuticals Co., Ltd and changed its name to Handok Inc. in July 2013. Handok Inc. was founded in 1954 and is based in Seoul, South Korea.


Keywords: Pharmaceutical Cancer Disease Medication Diabetes Healthcare Products Cancer Treatment Pharmacy In China Food Supplements Metabolic Disorders Taiho Pharmaceutical Johnson & Johnson Eye Disorders Medical Nutrition Products

Home Page: www.handok.co.kr

132 Teheran-ro
Seoul, 06235
South Korea
Phone: 82 2 527 5114


Officers

Name Title
Mr. Young-Jin Kim M.B.A. Chairman & CEO
Ms. Jeong-yol Cho Pres
Min-Bok Lee Managing Director
Byung-Chul Lee Assistance Managing Director
Jin-Gi Baek Sr. Managing Director
Shin-Gu Yeo Sr. Managing Director
Jin Ki Baek VP & Exec. Director
Doo-Seop Kim Exec. Officer

Exchange: KO

Country: KR

Currency: Korean Won (₩)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.6149
Price-to-Sales TTM: 0.4286
IPO Date:
Fiscal Year End: December
Full Time Employees: 0
Back to stocks